Description:
This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres
Sponsor:
Sirtex Medical
Contacts:
Janet Belljbell@sirtex.com
781-721-3840
Government Study Link:
NCT05967143 - Click here to see study onClinicalTrials.gov